National Dividend Paid And Capex Coverage Ratio from 2010 to 2024
| NHC Stock | USD 125.20 0.73 0.59% |
Dividend Paid And Capex Coverage Ratio | First Reported 2010-12-31 | Previous Quarter 1.75250942 | Current Value 1.88 | Quarterly Volatility 0.83453494 |
Check National HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National HealthCare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.9 M, Interest Expense of 307.8 K or Total Revenue of 710.2 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0438 or PTB Ratio of 1.96. National financial statements analysis is a perfect complement when working with National HealthCare Valuation or Volatility modules.
National | Dividend Paid And Capex Coverage Ratio |
Latest National HealthCare's Dividend Paid And Capex Coverage Ratio Growth Pattern
Below is the plot of the Dividend Paid And Capex Coverage Ratio of National HealthCare over the last few years. It is National HealthCare's Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National HealthCare's overall financial position and show how it may be relating to other accounts over time.
| Dividend Paid And Capex Coverage Ratio | 10 Years Trend |
|
Dividend Paid And Capex Coverage Ratio |
| Timeline |
National Dividend Paid And Capex Coverage Ratio Regression Statistics
| Arithmetic Mean | 1.39 | |
| Geometric Mean | 1.14 | |
| Coefficient Of Variation | 59.96 | |
| Mean Deviation | 0.58 | |
| Median | 1.47 | |
| Standard Deviation | 0.83 | |
| Sample Variance | 0.70 | |
| Range | 3.6436 | |
| R-Value | 0.27 | |
| Mean Square Error | 0.70 | |
| R-Squared | 0.07 | |
| Significance | 0.33 | |
| Slope | 0.05 | |
| Total Sum of Squares | 9.75 |
National Dividend Paid And Capex Coverage Ratio History
About National HealthCare Financial Statements
National HealthCare stakeholders use historical fundamental indicators, such as National HealthCare's Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although National HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in National HealthCare's assets and liabilities are reflected in the revenues and expenses on National HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National HealthCare. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 1.75 | 1.88 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out the analysis of National HealthCare Correlation against competitors. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.